Endoscopic Devices - Portugal | Statista Market Forecast

Revenue in the Endoscopic Devices market market in Portugal is anticipated to attain US$150.00m in 2024.
It is projected that revenue will exhibit an annual growth rate (CAGR 2024-2029) of 7.96%, culminating in a market volume of US$220.00m by 2029.
In a global context, the majority of revenue is expected to be produced the United States, where it will reach US$10.39bn in 2024.
In Portugal, the demand for endoscopic devices is experiencing significant growth, driven by advancements in minimally invasive surgical techniques and increasing healthcare investments.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market in Portugal is witnessing moderate growth, influenced by factors such as advancements in minimally invasive techniques, rising demand for outpatient procedures, and increased investment in healthcare infrastructure and technology.

Customer preferences: Consumers in Portugal are increasingly prioritizing minimally invasive procedures, resulting in a growing preference for endoscopic devices that promise quicker recovery times and reduced hospital stays. This trend is further fueled by an aging population that values efficient and less invasive treatment options. Additionally, there is a heightened awareness of personal health, with patients actively seeking out advanced medical technologies that enhance their treatment experience. The shift towards outpatient care is also reshaping patient expectations, driving demand for innovative endoscopic solutions.

Trends in the market: In Portugal, the Endoscopic Devices Market within the Medical Devices sector is experiencing a notable shift towards advanced minimally invasive surgical techniques. This trend is largely driven by an increasing demand for quicker recovery times and reduced hospital stays, particularly among the aging population. Healthcare providers are enhancing their offerings of innovative endoscopic solutions, responding to patients’ desires for more effective and efficient treatment options. Moreover, the rise of outpatient care is transforming the landscape, prompting stakeholders to invest in cutting-edge technologies and training to meet evolving patient expectations and improve overall healthcare delivery.

Local special circumstances: In Portugal, the Endoscopic Devices Market is shaped by the country's robust healthcare system and a strong emphasis on patient-centered care. The Portuguese population's increasing health consciousness, coupled with a cultural preference for minimally invasive procedures, fuels demand for advanced endoscopic solutions. Regulatory frameworks promote innovation while ensuring safety, encouraging local manufacturers to collaborate with international firms. Geographic diversity, with varying access to healthcare services, also drives investments in telemedicine and mobile surgical units, enhancing access to cutting-edge endoscopic treatments across urban and rural areas alike.

Underlying macroeconomic factors: The Endoscopic Devices Market in Portugal is significantly influenced by macroeconomic factors such as national economic stability, healthcare funding, and demographic trends. A growing GDP and increased public expenditure on health foster investments in advanced medical technologies, driving demand for endoscopic devices. Furthermore, the aging population and rising incidence of chronic diseases necessitate innovative healthcare solutions, prompting hospitals to adopt minimally invasive procedures. Favorable fiscal policies and support for research and development also encourage local manufacturers to innovate, while global supply chain dynamics enhance access to cutting-edge technologies, ensuring competitive market growth.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.